These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 9112465)

  • 21. Optimal timing of neutron irradiation for boron neutron capture therapy after intravenous infusion of sodium borocaptate in patients with glioblastoma.
    Kageji T; Nagahiro S; Kitamura K; Nakagawa Y; Hatanaka H; Haritz D; Grochulla F; Haselsberger K; Gabel D
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):120-30. PubMed ID: 11516861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
    Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
    Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computed tomography imaging of transferrin targeting liposomes encapsulating both boron and iodine contrast agents by convection-enhanced delivery to F98 rat glioma for boron neutron capture therapy.
    Miyata S; Kawabata S; Hiramatsu R; Doi A; Ikeda N; Yamashita T; Kuroiwa T; Kasaoka S; Maruyama K; Miyatake S
    Neurosurgery; 2011 May; 68(5):1380-7; discussion 1387. PubMed ID: 21273928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and boron uptake of BSH (Na2B12H11SH) in patients with intracranial tumors.
    Kageji T; Nakagawa Y; Kitamura K; Matsumoto K; Hatanaka H
    J Neurooncol; 1997 May; 33(1-2):117-30. PubMed ID: 9151229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular targeting and treatment of an epidermal growth factor receptor-positive glioma using boronated cetuximab.
    Wu G; Yang W; Barth RF; Kawabata S; Swindall M; Bandyopadhyaya AK; Tjarks W; Khorsandi B; Blue TE; Ferketich AK; Yang M; Christoforidis GA; Sferra TJ; Binns PJ; Riley KJ; Ciesielski MJ; Fenstermaker RA
    Clin Cancer Res; 2007 Feb; 13(4):1260-8. PubMed ID: 17317838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced boron uptake in RG 2 rat gliomas by electropermeabilization in vivo--a new possibility in boron neutron capture therapy.
    Ceberg CP; Brun A; Mir LM; Persson BR; Salford LG
    Anticancer Drugs; 1994 Aug; 5(4):463-6. PubMed ID: 7949252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical phase-I study of Na2B12H11SH (BSH) in patients with malignant glioma as precondition for boron neutron capture therapy (BNCT).
    Haritz D; Gabel D; Huiskamp R
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1175-81. PubMed ID: 8175403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative imaging and microlocalization of boron-10 in brain tumors and infiltrating tumor cells by SIMS ion microscopy: relevance to neutron capture therapy.
    Smith DR; Chandra S; Barth RF; Yang W; Joel DD; Coderre JA
    Cancer Res; 2001 Nov; 61(22):8179-87. PubMed ID: 11719448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Boron neutron capture therapy of brain tumors: investigation of urinary metabolites and oxidation products of sodium borocaptate by electrospray ionization mass spectrometry.
    Gibson CR; Staubus AE; Barth RF; Yang W; Kleinholz NM; Jones RB; Green-Church K; Tjarks W; Soloway AH
    Drug Metab Dispos; 2001 Dec; 29(12):1588-98. PubMed ID: 11717178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of sodium borocaptate: a critical assessment of dosing paradigms for boron neutron capture therapy.
    Gibson CR; Staubus AE; Barth RF; Yang W; Ferketich AK; Moeschberger MM
    J Neurooncol; 2003; 62(1-2):157-69. PubMed ID: 12749711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell culture and animal studies for intracerebral delivery of borocaptate in liposomal formulation.
    Ji B; Chen W; Lu DR; Halpern DS
    Drug Deliv; 2001; 8(1):13-7. PubMed ID: 11280438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of electroporation on cell killing by boron neutron capture therapy using borocaptate sodium (10B-BSH).
    Ono K; Kinashi Y; Masunaga S; Suzuki M; Takagaki M
    Jpn J Cancer Res; 1998 Dec; 89(12):1352-7. PubMed ID: 10081497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response of rat skin to boron neutron capture therapy with p-boronophenylalanine or borocaptate sodium.
    Morris GM; Coderre JA; Hopewell JW; Micca PL; Rezvani M
    Radiother Oncol; 1994 Aug; 32(2):144-53. PubMed ID: 7972908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
    Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electroporation increases the effect of borocaptate (10B-BSH) in neutron capture therapy.
    Ono K; Kinashi Y; Masunaga S; Suzuki M; Takagaki M
    Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):823-6. PubMed ID: 9845104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of tumor growth in a glioma model treated with boron neutron capture therapy.
    Goodman JH; McGregor JM; Clendenon NR; Gahbauer RA; Barth RF; Soloway AH; Fairchild RG
    Neurosurgery; 1990 Sep; 27(3):383-8. PubMed ID: 2234330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
    Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biodistribution of 10B in a rat liver tumor model following intra-arterial administration of sodium borocaptate (BSH)/degradable starch microspheres (DSM) emulsion.
    Suzuki M; Nagata K; Masunaga S; Kinashi Y; Sakurai Y; Maruhashi A; Ono K
    Appl Radiat Isot; 2004 Nov; 61(5):933-7. PubMed ID: 15308171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumors.
    Yang W; Barth RF; Wu G; Huo T; Tjarks W; Ciesielski M; Fenstermaker RA; Ross BD; Wikstrand CJ; Riley KJ; Binns PJ
    J Neurooncol; 2009 Dec; 95(3):355-365. PubMed ID: 19588228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pretreatment with buthionine sulfoximine enhanced uptake and retention of BSH in brain tumor.
    Yoshida F; Yamamoto T; Nakai K; Zaboronok A; Matsuda M; Akutsu H; Ishikawa E; Shirakawa M; Matsumura A
    Appl Radiat Isot; 2014 Jun; 88():86-8. PubMed ID: 24731546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.